| Section | Status | CCG | Name |
| 01.05.03 | Formulary |  |
Adalimumab |
| 13.05.03 | Restricted Use | |
Adalimumab Humira® |
| 02.12 | Formulary | |
Alirocumab Praluent® |
| 13.05.02 | Formulary | |
Apremilast Otezla® |
| 09.01.04 | Formulary | |
Avatrombopag Doptelet® |
| 04.12 | Formulary | |
Botulinum neurotoxin Type A Xeomin® |
| 10.01.03 | Restricted Use | |
Brodalumab Kyntheum® |
| 08.03.04.02 | Formulary | |
Degarelix Firmagon® |
| 13.05.03 | Formulary | |
Dimethyl fumerate Skilarence® |
| 13.05.03 | Formulary | |
Dupilumab Dupixent® |
| 09.01.04 | Formulary | |
Eltrombopag Revolade® |
| 02.12 | Formulary | |
Evolocumab Repatha® |
| 06.01.06 | Formulary | |
Flash glucose monitoring system FreeStyle Libre® |
| 04.07.04.02 | Formulary | |
Fremanezumab |
| 01.05.03 | Formulary | |
Golimumab Simponi® |
| 10.01.03 | Restricted Use | |
Golimumab Simponi® |
| 13.05.03 | Formulary | |
Guselkumab Tremfya® |
| 01.05.03 | Formulary | |
Infliximab |
| 13.05.03 | Restricted Use | |
Ixekizumab Taltz® |
| 09.05.02.02 | Formulary | |
Lanthanum Fosrenol ® |
| 09.01.04 | Formulary | |
Lusutrombopag Mulpleo® |
| 03.04.02 | Restricted Use | |
Omalizumab |
| 07.04.03 | Formulary | |
Pentosan polysulfate sodium Elmiron® |
| 13.05.03 | Formulary | |
Risankizumab Skyrizi® |
| 09.01.04 | Formulary | |
Romiplostim Nplate® |
| 09.05.02.02 | Formulary | |
Sevelamer Carbonate tablets |
| 13.05.03 | Formulary | |
Tildrakizumab Ilumetri® |
| 01.05.03 | Formulary | |
Tofacitinib Xeljanz® |
| 10.01.03 | Formulary | |
Tofacitinib Xeljanz ® |
| 06.05.02 | Restricted Use | |
Tolvaptan Jinarc® |
| 01.05.03 | Formulary | |
Ustekinumab Stelara® |
| 13.05.03 | Formulary | |
Ustekinumab |
| 01.05.03 | Formulary | |
Vedolizumab Entyvio® |